Efficacy of Dula on the colonic expression level of TFF-3: intestinal barrier function TFF3 enhances intestinal barrier function via the regulation of tight junctions to decrease the paracellular permeability of the intestinal epithelium
Individual factors such as weight-loss goals, existing medical conditions, budget, and local availability determine the best option
It provides broad nutritional support in one consistent step and may help fill common gaps that can develop when food intake becomes lower
Other medications include orlistat , phentermine/topiramate , lorcaserin (recently withdrawn from the market), and bupropion/naltrexone
Not intended for individuals under 18, pregnant or nursing individuals, or anyone with a known medical condition or taking medication including GLP-1 medications
Unfortunately not with us